Recombinant factor VIIa for treatment of a child with severe factor VII deficiency and coarctation of the aorta [3]

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 7, 2003, Pages 591-

  Maimon, Michal ^a   Bernstein, Tamar ^a   Kenet, Gili ^b   Kapelushnik, Joseph ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b National Hemophilia Center   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; FRESH FROZEN PLASMA; PROSTAGLANDIN E2; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

AORTA COARCTATION; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING TEST; CASE REPORT; DISEASE SEVERITY; HEART SURGERY; HUMAN; LETTER; LOW DRUG DOSE; MALE; NEWBORN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR;

AORTIC COARCTATION; FACTOR VIIA; HUMANS; INFANT, NEWBORN; RECOMBINANT PROTEINS; REFERENCE VALUES;

EID: 0037972703     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200307000-00024     Document Type: Letter

References (10)

1. Mariani G, Mazzucconi MG, Hermans J, et al. Factor VII deficiency: Immunological characterisation of genetic variants and detection of carriers. Br J Haematol. 1981;48:7-14.
2. Girolami A, Falezza G, Patrassi G, et al. Factor VII Verona coagulation disorder: Double heterozygous factor VII deficiency. Blood. 1977;50:603-610.
3. 2: Another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern. Blood. 1979;54:46-53.
4. Wion KL, Kelly D, Summerfield JA, et al. Distribution of factor VII in RNA and antigen in human liver and other tissues. Nature. 1985;317:726-729.
5. Biron C, Bengler C, Gris JC, Schved JF. Acquired factor VII deficiency during sepsis. Haemostasis. 1997;27:51-56.
6. Factor VII: Company core data sheet. Health care regulatory affairs, HCRAMED, NovoSeven, Novo Nordisk, 1998.
7. van Nieuwenhuizen RC, Peters M, Lubbers LJ, et al. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart. 1999;82:40-46.
8. Patrassi GM, Sartori MT, Viero M, et al. Protein C, factor VII and prothrombin time as early markers of liver function recovery or failure after liver transplantation. Blood Coagul Fibrinolysis. 1993;4:863-867.
9. Wong WY, Huang WC, Miller R, et al. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia. 2000;6:50-54.
10. Cohen LJ, McWilliams NB, Neuberg R, et al. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: A summary of case reports. Am J Hematol. 1995;50:269-276.